Intrauterine Devices: Effective Contraception with Noncontraceptive Benefits for Adolescents

Adeyemi-Fowode OA, Oluyemisi A Adeyemi-Fowode, Oluyemisi Adeyemi‐Fowode, Bercaw-Pratt JL, Jennifer L Bercaw-Pratt, Jennifer L. Bercaw‐Pratt
Journal of pediatric and adolescent gynecology · 2019 · vol. 32(5) , pp. S2–S6 · doi:10.1016/j.jpag.2019.07.001 · PMID:31585615 · W2978146015
review OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review examines the efficacy and safety of intrauterine devices (IUDs) for adolescent contraception, highlighting their noncontraceptive benefits such as reduced menstrual pain and bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Although adolescent pregnancy and birth rates have been declining since the early 1990s, the rate of intrauterine device (IUD) use in adolescents remain low. IUDs are a highly effective contraceptive method with a failure rate of less than 1%. There are currently 5 IUDs available and marketed in the United States: the nonhormonal copper-containing IUD (Paragard Copper T380A; Ortho-McNeil) and 4 hormonal levonorgestrel-releasing intrauterine systems (LNG-IUDs). IUDs can be used in adolescents, and the LNG-IUD has many noncontraceptive benefits including the treatment of heavy menstrual bleeding, dysmenorrhea, pelvic pain/endometriosis, and endometrial hyperplasia/endometrial cancer. In addition, the LNG-IUD is an effective tool for suppression of menses.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosis

MeSH descriptors

Contraception Contraceptive Agents, Female Intrauterine Devices Adolescent Contraception Contraceptive Agents, Female Dysmenorrhea Dysmenorrhea Endometriosis Endometriosis Female Humans Intrauterine Devices Menorrhagia Menorrhagia Menstruation Menstruation Pregnancy Pregnancy in Adolescence Pregnancy in Adolescence

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (58)

Cited by (3)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:29.487098+00:00
License: CC0 · commercial use OK